Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clearing the air on Codex

This article was originally published in The Tan Sheet

Executive Summary

The Codex Draft Guidelines for Vitamin and Mineral Food Supplements "will not restrict U.S. consumers' access to vitamin and mineral supplements or impose any restrictions that go beyond those established by U.S. law," FDA says in a recent document answering frequently asked questions about the Codex Commission. U.S. participation in the Codex process is "important to encourage the development of guidelines on vitamin and mineral supplements that are based on sound science and not on arbitrary criteria," the agency notes. The document coincides with CRN's release of "Myths and Facts on Codex and WTO." Prepared by VP - Scientific & International Affairs John Hathcock, PhD, the document dispels "myths" such as the belief that Codex regs will "become binding internationally"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel